Search Within

David Scheinberg

  1. "Biostatistics Service"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (9)
Groups
  1. Adult Leukemia (28)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  3. Biostatistics Service (28)
  4. Center for Hematologic Malignancies (28)
  5. Department of Medicine (28)
  6. Epidemiology and Biostatistics (28)

More Groups

People
  1. Katherine Panageas (13)
  2. Joseph Jurcic (10)
  3. Peter Maslak (10)
  4. Mark Heaney (7)
  5. Glenn Heller (6)
  6. Nicole Lamanna (6)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2017 (4)
  4. 2016 (3)
  5. 2014 (1)
  6. 2012 (1)

More Years

Publications
  1. Blood (7)
  2. Journal of Clinical Oncology (6)
  3. Clinical Cancer Research (2)
  4. Journal of Nuclear Medicine (2)
  5. Leukemia (2)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (6)
  3. American Association for Cancer Research (3)
  4. Nature Publishing Group (3)
  5. Society of Nuclear Medicine (2)
  6. Amer Soc Clinical Investigation Inc (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies
    Journal Article

    Casey, E.; Bournazos, S.; Mo, G.; Mondello, P.; Tan, K. S.; Ravetch, J. V.; Scheinberg, D. A.
    Leukemia (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Journal Article

    Mathias, M. D.; Sockolosky, J. T.; Chang, A. Y.; Tan, K. S.; Liu, C.; Garcia, K. C.; Scheinberg, D. A.
    Leukemia (2017)

    Fulltext@MSK | Save
  • Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations
    Journal Article

    Mondello, P.; Brea, E. J.; De Stanchina, E.; Toska, E.; Chang, A. Y.; Fennell, M.; Seshan, V.; Garippa, R.; Scheinberg, D. A.; Baselga, J.; more...
    JCI Insight (2017)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Journal Article

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V.; Hendrickson, R. C.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
    Journal Article

    Şenbabaoğlu, Y.; Gejman, R. S.; Winer, A. G.; Liu, M.; Van Allen, E. M.; de Velasco, G.; Miao, D.; Ostrovnaya, I.; Drill, E.; Luna, A.; more...
    Genome Biology (2016)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save